Antibodies. The rabbit anti-z antiserum 448 (9) and the anti-hCD3d antibody (APA1/2) (10) have been previously described. Jovi1 (anti-hCb1) was provided by M. Owen (GlaxoSmithKline, Herts, UK), UCHT1 (anti-hCD3e) was provided by P. Beverly (The Edward Jenner Institute for Vaccine Research, Compton, UK), 145-2C11 (anti-mCD3e) was provided by J. Bluestone (University of California, San Francisco, San Francisco, CA), and HMT3.2 (antihCD3g) was provided by R. Kubo (Gemini Science Inc., La Jolla, CA). The following reagents were purchased: 17A2 (anti-mCD3g), GL3-PE (anti-mTCRgd), biotin-labeled 145-2C11, goat anti-mouse FITC, and streptavidin-Cy5 (BD Biosciences); 7D6 (anti-mCD3g; Biocarta Europe GmbH); 12CA5 (anti-HA tag; Roche); 5A6.E9 (anti-hTCRgd; Pierce Chemical Co.); bF1 (anti-hTCRb; Endogen); M20d (anti-CD3d) and M20 (anti-CD3e; Santa Cruz Biotechnology, Inc.); G3 (anti-z; Abcam); 4G10 (antiphosphotyrosine; Upstate Biotechnology); goat anti-rabbit IgG-HRPO and rabbit anti-goat IgG-HRPO (Pierce Chemical Co.); OKT3 (anti-hCD3e; American Type Culture Collection); anti-CD4 and anti-CD8 (Immunotech); 11F2 (anti-hTCRgd; BD Biosciences); Immu510 (anti-hTCRd; Beckman Coulter) and SK7 (anti-hCD3e; StemCell Technologies Inc.); UCHT1-Alexa Fluor 647 (anti-hCD3e; Biozol); and goat anti-mouse IgG-PE (Southern Biotechnology Associates, Inc.).
